Glioblastoma (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Scientists have learned that not all GBMs are the same—they can vary significantly based on their tumor microenvironment (TME), which includes the surrounding cells, molecules, and blood vessels that support tumor growth. Understanding these differences is essential for developing treatments that target …
Single-nucleus RNA sequencing reveals a preclinical model for the most common subtype of glioblastoma
Share.
